Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells
- PMID: 7510125
Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells
Abstract
Interactions between insulin-like growth factor I (IGF-I) and the type of I IGF receptor may be affected by high-affinity extracellular binding proteins. To date, six distinct IGF binding proteins (IGFBPs) have been identified, but their physiological roles are not well understood. For example, depending on experimental conditions, IGFBP-1 has been shown to both enhance and inhibit IGF-I mediated mitogenesis. We have previously shown that excess exogenous IGFBP-1 inhibited IGF-I mediated growth of MCF-7 cells. In this study, we examined whether or not endogenously expressed IGFBP-1 could interfere with IGF-I mediated growth of MCF-7 cells. Cells were stably transfected with an IGFBP-1 expression vector. IGFBP-1 mRNA was produced by the cells, and protein was detected in the conditioned media by ligand blot and immunoblot. Type I IGF receptor could not be phosphorylated by IGF-I in cells expressing IGFBP-1; however, an IGF-I analogue (Arg-3-IGF-I), which cannot complex with IGFBPs, stimulated receptor phosphorylation. IGF-I did not stimulate cell growth in IGFBP-1 expressing cells. These results suggest that IGFBP-1 expression in MCF-7 breast cancer cells inhibits IGF-I induced growth by interrupting the interaction between IGF-I and its receptor.
Similar articles
-
Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.J Cell Physiol. 1994 Jan;158(1):69-78. doi: 10.1002/jcp.1041580110. J Cell Physiol. 1994. PMID: 7505280
-
Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.Cancer Res. 1993 Oct 1;53(19):4680-5. Cancer Res. 1993. PMID: 7691401
-
Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.J Cell Physiol. 1993 Jun;155(3):556-67. doi: 10.1002/jcp.1041550314. J Cell Physiol. 1993. PMID: 7684042
-
The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer.Breast Cancer Res Treat. 1992;22(1):81-90. doi: 10.1007/BF01833336. Breast Cancer Res Treat. 1992. PMID: 1384805 Review.
-
IGF binding proteins: regulation of cellular actions.Growth Regul. 1992 Jun;2(2):80-7. Growth Regul. 1992. PMID: 1283101 Review.
Cited by
-
Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid.Br J Cancer. 1995 Dec;72(6):1447-53. doi: 10.1038/bjc.1995.528. Br J Cancer. 1995. PMID: 8519658 Free PMC article.
-
Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities.Front Endocrinol (Lausanne). 2024 May 30;15:1396192. doi: 10.3389/fendo.2024.1396192. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38872970 Free PMC article. Review.
-
GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.Mol Cell Endocrinol. 2016 Feb 15;422:160-171. doi: 10.1016/j.mce.2015.11.033. Epub 2015 Dec 13. Mol Cell Endocrinol. 2016. PMID: 26690777 Free PMC article.
-
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.Mol Cancer Res. 2017 Apr;15(4):489-497. doi: 10.1158/1541-7786.MCR-16-0176. Epub 2017 Jan 17. Mol Cancer Res. 2017. PMID: 28096479 Free PMC article.
-
Insulin-like growth factor binding proteins (IGFBPs) in breast cancer.J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):75-84. doi: 10.1023/a:1009519400591. J Mammary Gland Biol Neoplasia. 2000. PMID: 10791770 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials